AssetMark’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
Other funds holding LMAT
AssetMark's LMAT Position: Q3 2026 in Review
AssetMark reduced its LeMaitre Vascular (LMAT) stake by 5.5% in Q3 2026, selling an estimated $531 and leaving 104 shares worth $8.59K. The position accounts for ﹤0.01% of the portfolio, ranked #2568.
AssetMark first reported a position in LMAT in Q4 2017 and has held it in 7 quarters since. The position peaked at $12K in Q1 2026. 243 funds tracked by Wall St. Rank hold LMAT as of Q3 2026.
- AssetMark held 104 shares of LeMaitre Vascular worth $8.59K as of Q3 2026.
- AssetMark sold 6 LeMaitre Vascular shares in Q3 2026, an estimated $531.
- LeMaitre Vascular made up ﹤0.01% of AssetMark's portfolio in Q3 2026, its #2568 holding.
- AssetMark first reported a position in LeMaitre Vascular in Q4 2017 and has held it in 7 quarters since.
- AssetMark's LeMaitre Vascular position peaked at $12K in Q1 2026.
- 243 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2026.
Based on AssetMark's 13F filing for Q3 2026, filed 21 Oct 2026.